Atrial Fibrillation New Onset
45
9
11
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.7%
3 terminated out of 45 trials
83.3%
-3.2% vs benchmark
18%
8 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (45)
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Intelligent Monitoring to Predict Atrial Fibrillation
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Effect of Left Posterior Pericardiotomy for the Prevention of POAF
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
The Effect of Education Given to Patients with Atrial Fibrillation on Anxiety Levels
PARADISE: Predicting AF After Cardiac Surgery
Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated.
PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry
Obstructive Sleep Apnoea and Cardiac Arrhythmias
Tracking Atrial Fibrillation After Intensive Care Admission
Promoting Atrial Fibrillation Screening in Primary Care
STROKESTOP III - Optimized Method for Atrial Fibrillation Screening